Abstract
Background:
Continuous glucose monitoring (CGM) has come a long way and is standard for patients with type 1 diabetes and many with type 2 diabetes. Several attempts to establish noninvasive glucose monitoring, that is, measuring glucose without puncturing the skin, have not been successful yet.
Method:
A different approach is the monitoring of volatile organic compounds in breath.
Results:
This addresses a number of limitations of current invasive glucose monitoring techniques. This should enhance compliance, adherence, clinical outcomes, and quality of life. It might also reduce costs associated with CGM.
Conclusions:
A recent publication in this journal indicates the clinical value of this approach by presenting data from a clinical study. The respective pros and cons will be discussed briefly.
Get full access to this article
View all access options for this article.